1. Home
  2. OSS vs EOLS Comparison

OSS vs EOLS Comparison

Compare OSS & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OSS

One Stop Systems Inc.

HOLD

Current Price

$16.20

Market Cap

408.4M

Sector

Technology

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$7.15

Market Cap

407.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSS
EOLS
Founded
1998
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
408.4M
407.0M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
OSS
EOLS
Price
$16.20
$7.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$10.00
$15.50
AVG Volume (30 Days)
1.3M
710.6K
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
133.85
1.23
EPS
N/A
N/A
Revenue
$37,027,382.00
$297,176,000.00
Revenue This Year
$22.19
$13.27
Revenue Next Year
$20.67
$17.62
P/E Ratio
N/A
N/A
Revenue Growth
34.46
11.61
52 Week Low
$3.46
$3.86
52 Week High
$20.88
$10.20

Technical Indicators

Market Signals
Indicator
OSS
EOLS
Relative Strength Index (RSI) 46.43 65.39
Support Level $14.48 $5.95
Resistance Level $17.33 $7.36
Average True Range (ATR) 1.54 0.34
MACD -0.35 0.00
Stochastic Oscillator 23.44 96.67

Price Performance

Historical Comparison
OSS
EOLS

About OSS One Stop Systems Inc.

One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: